慢性病防治专栏

血清黏附因子与甘油三酯-葡萄糖指数对老年高血压合并代谢相关脂肪性肝病患者颈动脉病变的诊断价值

  • 王秀杰 ,
  • 张国栋 ,
  • 乔振国 ,
  • 孙齐缘 ,
  • 李赓煦 ,
  • 翟国杰 ,
  • 焦雪花
展开
  • 1.苏州大学附属苏州九院,徐州医科大学附属苏州湾临床学院,苏州市第九人民医院,内分泌科
    3.苏州大学附属苏州九院,徐州医科大学附属苏州湾临床学院,苏州市第九人民医院,消化内科
    4.苏州大学附属苏州九院,徐州医科大学附属苏州湾临床学院,苏州市第九人民医院 神经内科 (江苏 苏州 215200 )
    2.苏州永鼎医院内分泌科 (江苏 苏州 215200 )

收稿日期: 2025-09-17

  网络出版日期: 2026-02-25

基金资助

江苏省中医药科技发展计划项目(MS2023096);苏州市科技发展计划项目(SYSD2020203);苏州市科技计划项目(SLT2023203);苏州市中西医结合科研基金(SYWD2024322);徐州医科大学附属医院发展基金项目(XYFZ202202);苏州工业园区东方华夏心血管健康研究院天然调脂药物循证科研基金项目(2023-CCA-NLD-348)

Study of the diagnostic value of serum adhesion factors and the triglyceride-glucose index for carotid artery lesions in elderly hypertensive patients with metabolically associated fatty liver disease

  • Xiujie WANG ,
  • Guodong ZHANG ,
  • Zhenguo QIAO ,
  • Qiyuan SUN ,
  • Gengxu LI ,
  • Guojie ZHAI ,
  • Xuehua JIAO
Expand
  • 1.Endocrinology Department,Suzhou Ninth Affiliated Hospital of Suzhou University,Xuzhou Medical University Affiliated Suzhou Bay Clinical College,Suzhou Ninth People's Hospital,Suzhou 215200,Jiangsu,China
    3.Digestive System Department,Suzhou Ninth Affiliated Hospital of Suzhou University,Xuzhou Medical University Affiliated Suzhou Bay Clinical College,Suzhou Ninth People's Hospital,Suzhou 215200,Jiangsu,China
    4.Department of Neurology,Suzhou Ninth Affiliated Hospital of Suzhou University,Xuzhou Medical University Affiliated Suzhou Bay Clinical College,Suzhou Ninth People's Hospital,Suzhou 215200,Jiangsu,China
    2.Endocrinology Department,Suzhou Yongding Hospital,Suzhou 215200,Jiangsu,China

Received date: 2025-09-17

  Online published: 2026-02-25

摘要

目的 探究血清细胞间黏附分子-1(ICAM-1)、血管细胞黏附分子-1(VCAM-1)与甘油三酯-葡萄糖指数(TyG指数)对老年高血压合并代谢相关脂肪性肝病(MASLD)患者颈动脉病变的诊断价值。 方法 回顾性研究选取2021年6月至2023年7月医院收治的老年高血压合并MASLD患者共189例作为本次研究对象,采用彩色多普勒超声诊断仪检测所有患者颈动脉内膜中层厚度(IMT),并根据IMT检测结果将患者分为IMT正常组(IMT < 1.0 mm)和IMT增厚组(IMT > 1.0 mm),收集并分析两组患者一般资料,采用酶联免疫吸附法检测患者血清ICAM-1、VCAM-1水平,由空腹血糖及甘油三酯计算得到TyG指数,比较两组患者相关指标的差异性。采用多因素logistic回归分析老年高血压合并MASLD患者IMT增厚的危险因素,应用Pearson相关性分析血清ICAM-1、VCAM-1及TyG指数与IMT增厚的相关性,根据受试者工作特征(ROC)曲线下面积评估血清ICAM-1、VCAM-1及TyG指数单一检测以及联合检测对老年高血压合并MASLD患者颈动脉病变的诊断效能。 结果 根据IMT检测结果共有71例患者IMT增厚,占比37.57%,通过对比显示,IMT增厚组患者收缩压、舒张压、甘油三酯、AST、ALT水平均高于IMT正常组(P < 0.05),血清ICAM-1、VCAM-1水平,以及TyG指数均较IMT正常组更高(P < 0.05);logistic回归分析显示,老年高血压合并MASLD患者收缩压、舒张压、甘油三酯、天冬氨酸氨基转移酶(AST)、丙氨酸氨基转移酶(ALT)、ICAM-1、VCAM-1水平以及TyG指数、空腹胰岛素(FINS)升高是IMT增厚的主要危险因素;通过Pearson相关性分析得出,血清ICAM-1、VCAM-1以及TyG指数与老年高血压合并MASLD患者IMT增厚均呈正相关(P < 0.05);ROC曲线结果显示,血清ICAM-1、VCAM-1以及TyG指数联合检测诊断老年高血压合并MASLD患者IMT增厚的AUC高于各指标单独检测(P < 0.05)。 结论 血清ICAM-1、VCAM-1及TyG指数在诊断老年高血压合并MASLD患者IMT增厚方面具有较高的敏感度和特异度,提示其可能作为辅助工具,在该类患者的颈动脉病变风险评估中发挥重要作用。

本文引用格式

王秀杰 , 张国栋 , 乔振国 , 孙齐缘 , 李赓煦 , 翟国杰 , 焦雪花 . 血清黏附因子与甘油三酯-葡萄糖指数对老年高血压合并代谢相关脂肪性肝病患者颈动脉病变的诊断价值[J]. 实用医学杂志, 2026 , 42(4) : 603 -610 . DOI: 10.3969/j.issn.1006-5725.2026.04.009

Abstract

Objective To assess the diagnostic effectiveness of intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and the triglyceride-glucose index (TyG index) in detecting abnormalities of carotid artery intima-media thickness (IMT) in elderly hypertensive patients with metabolically associated steatotic liver disease (MASLD). Methods A retrospective analysis was carried out on 189 elderly hypertensive patients with MASLD who were admitted to our institution between June 2021 and July 2023. All the subjects had their carotid IMT measured by color Doppler ultrasound and were classified into two groups: the normal group (IMT < 1.0 mm) and the thickened group (IMT ≥ 1.0 mm) according to the ultrasound results. Clinical data collection involved quantifying serum ICAM-1 and VCAM-1 by enzyme - linked immunosorbent assay (ELISA), calculating the triglyceride glucose (TyG) index from fasting glucose and triglyceride levels, and conducting a comparative analysis of the differences in relevant parameters between the groups. Multivariate logistic regression was used to identify the independent risk factors for IMT thickening, and Pearson correlation analysis was employed to assess the relationships between serum biomarkers and the IMT status. The diagnostic performance was evaluated through receiver operating characteristic (ROC) curve analysis. Results IMT thickening was detected in 71 patients (37.57%). In comparison with the normal IMT group, the thickened IMT group showed significantly higher levels of systolic/diastolic blood pressure, triglycerides, aspartate aminotransferase (AST), alanine aminotransferase (ALT), serum ICAM - 1, VCAM - 1, and TyG index (all P < 0.05). Logistic regression analysis confirmed that these parameters were independent risk factors for IMT thickening. The levels of serum ICAM - 1, VCAM - 1, and TyG index were positively correlated with IMT thickening (IMT ≥1.0 mm) (all P < 0.05). ROC analysis indicated that the combined biomarker assessment had better diagnostic accuracy than individual markers (P < 0.05). Conclusions Serum ICAM-1, VCAM-1, and the TyG index exhibit high diagnostic sensitivity and specificity for IMT abnormalities in this patient population, which validates their utility as adjunctive tools for carotid artery lesion risk stratification in elderly hypertensive patients with MASLD.

参考文献

[1] RINELLA M E, NEUSCHWANDER-TETRI B A, SIDDIQUI M S, et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease[J]. Hepatology, 2023, 77(5): 1797-1835. doi:10.1097/HEP.0000000000000323 .
[2] DUELL P B, WELTY F K, MILLER M, et al. Nonalcoholic fatty liver disease and cardiovascular risk: A scientific statement from the American heart association[J]. Arterioscler Thromb Vasc Biol, 2022, 42(6): e168-e185. doi:10.1161/atv.0000000000000153 .
[3] LIAO J, WANG L, DUAN L, et al. Association between estimated glucose disposal rate and cardiovascular diseases in patients with diabetes or prediabetes: A cross-sectional study[J]. Cardiovasc Diabetol, 2025, 24(1): 13. doi:10.1186/s12933-024-02570-y .
[4] 杨慧琼, 尹磊, 杨晓芳, 等. 银杏酮酯滴丸对稳定型心绞痛患者心绞痛发作及外周血miR-29a、ICAM-1水平的影响[J]. 实用医学杂志, 2024, 40(16): 2340-2346. doi:10.3969/j.issn. 1006-5725.2024.16.022 .
[5] ESWARAN S, GEBERT L, SCHRAVEN S, et al. Intercellular adhesion molecule-1 protects against adipose tissue inflammation and insulin resistance but promotes liver disease activity in western-diet fed mice[J]. Sci Rep, 2025, 15(1): 25884. doi:10.1038/s41598-025-11555-0 .
[6] DI ZEO-SáNCHEZ D E, DíAZ-ALBEROLA I, PINAZO-BANDERA J M, et al. Intestinal permeability and immune-inflammatory markers in patients with idiosyncratic drug-induced liver injury, drug-induced steatosis and metabolic dysfunction-associated steatotic liver disease (MASLD)[J]. Br J Pharmacol, 2025, 182(21): 5303-5316. doi:10.1111/bph.70123 .
[7] LONGO L, GUERREIRO G T S, BEHRENS L, et al. Rifaximin prophylaxis in MASLD-hepatocellular carcinoma: Lessons from a negative animal model[J]. Biomed Rep, 2024, 22(1): 4. doi:10.3892/br.2024.1882 .
[8] TAN L, LIU Y, LIU J, et al. Association between insulin resistance and uncontrolled hypertension and arterial stiffness among US adults: A population-based study[J]. Cardiovasc Diabetol, 2023, 22(1): 311. doi:10.1186/s12933-023-02038-5 .
[9] 陆再英. 内科学[M]. 7版. 北京: 人民卫生出版社, 2008: 227.
[10] 中国高血压防治指南修订委员会.中国高血压防治指南2010 [J]. 中华高血压杂志, 2011, 19(8): 701-743. doi:10.3760/cma.j.issn.0253-3758.2011.07.002 .
[11] 薛芮, 范建高. 代谢相关脂肪性肝病新定义的国际专家共识简介[J]. 临床肝胆病杂志, 2020, 36(6): 1224-1227. doi:10.3969/j.issn.1001-5256.2020.06.007 .
[12] CHEN X, LI A, MA Q. Association of estimated glucose disposal rate with metabolic syndrome prevalence and mortality risks: A population-based study[J]. Cardiovasc Diabetol, 2025, 24(1): 38. doi:10.1186/s12933-025-02599-7 .
[13] ARMANDI A, BUGIANESI E. Extrahepatic outcomes of nonalcoholic fatty liver disease: Cardiovascular diseases[J]. Clin Liver Dis, 2023, 27(2): 239-250. doi:10.1016/j.cld.2023.01.018 .
[14] SHAO C, XU L, LEI P, et al. Metabolomics to identify fingerprints of carotid atherosclerosis in nonobese metabolic dysfunction-associated fatty liver disease[J]. J Transl Med, 2023, 21(1): 12. doi:10.1186/s12967-022-03760-6 .
[15] ZHANG H, TU Z, LIU S, et al. Association of different insulin resistance surrogates with all-cause and cardiovascular mortality among the population with cardiometabolic multimorbidity[J]. Cardiovasc Diabetol, 2025, 24(1): 33. doi:10.1186/s12933-025-02576-0 .
[16] LIU B, SU L, LOO S J, et al. Matrix metallopeptidase 9 contributes to the beginning of plaque and is a potential biomarker for the early identification of atherosclerosis in asymptomatic patients with diabetes[J]. Front Endocrinol, 2024, 15: 1369369. doi:10.3389/fendo.2024.1369369 .
[17] TICALA M, RUSU C C, MOLDOVAN D, et al. Relationship between vascular cell adhesion molecule-1 (VCAM-1), soluble receptor for advanced glycation end products (sRAGE) and functional hemodynamic parameters of arteriovenous fistula[J]. J Vasc Access, 2022, 23(1): 67-74. doi:10.1177/1129729820976264 .
[18] DUAN M, ZHAO X, LI S, et al. Metabolic score for insulin resistance (METS-IR) predicts all-cause and cardiovascular mortality in the general population: Evidence from NHANES 2001-2018[J]. Cardiovasc Diabetol, 2024, 23(1): 243. doi:10.1186/s12933-024-02334-8 .
[19] SON D H, LEE H S, LEE Y J, et al. Comparison of triglyceride-glucose index and HOMA-IR for predicting prevalence and incidence of metabolic syndrome[J]. Nutr Metab Cardiovasc Dis, 2022, 32(3): 596-604. doi:10.1016/j.numecd.2021.11.017 .
[20] YAN H, ZHOU Q, WANG Y, et al. Associations between cardiometabolic indices and the risk of diabetic kidney disease in patients with type 2 diabetes[J]. Cardiovasc Diabetol, 2024, 23(1): 142. doi:10.1186/s12933-024-02228-9 .
[21] LIN Z, YUAN S, LI B, et al. Insulin-based or non-insulin-based insulin resistance indicators and risk of long-term cardiovascular and all-cause mortality in the general population: A 25-year cohort study[J]. Diabetes Metab, 2024, 50(5): 101566. doi:10.1016/j.diabet.2024.101566 .
[22] SHIN J, BRESSLER J, GROVE M L, et al. DNA methylation markers of insulin resistance surrogate measures in the Atherosclerosis Risk in Communities (ARIC) study[J]. Epigenetics, 2025, 20(1): 2498857. doi:10.1080/15592294.2025.2498857 .
[23] DE BAKKER M, KRAAN J, AKKERHUIS K M, et al. Longitudinal profile of circulating endothelial cells in post-acute coronary syndrome patients[J]. Biomarkers, 2023, 28(2): 152-159. doi:10.1080/1354750X.2022.2162966 .
[24] SONG J, MA R, YIN L. Associations between estimated glucose disposal rate and arterial stiffness and mortality among US adults with non-alcoholic fatty liver disease[J]. Front Endocrinol, 2024, 15: 1398265. doi:10.3389/fendo.2024.1398265 .
[25] WANG B, YANG Y, LI X. Interaction of hypertension and insulin resistance exacerbates the occurrence of diabetes mellitus in healthy individuals[J]. J Diabetes Res, 2022, 2022: 9289812. doi:10.1155/2022/9289812 .
[26] MIAO M, ZHOU G, BAO A, et al. Triglyceride-glucose index and common carotid artery intima-media thickness in patients with ischemic stroke[J]. Cardiovasc Diabetol, 2022, 21(1): 43. doi:10.1186/s12933-022-01472-1 .
[27] YU H, TAO L, LI Y G, et al. Association between triglyceride-glucose index trajectories and carotid atherosclerosis progression[J]. Cardiovasc Diabetol, 2023, 22(1): 130. doi:10.1186/s12933-023-01847-y .
[28] NABIPOORASHRAFI S ALI, SEYEDI S A, RABIZADEH S, et al. The accuracy of triglyceride-glucose (TyG) index for the screening of metabolic syndrome in adults: A systematic review and meta-analysis[J]. Nutr Metab Cardiovasc Dis, 2022, 32(12): 2677-2688. doi:10.1016/j.numecd.2022.07.024 .
[29] ZHENG X, ZHANG W, YANG F, et al. Evaluative performance of TyG-ABSI versus traditional indices in relation to cardiovascular disease and mortality: Evidence from the U.S. NHANES[J]. Cardiovasc Diabetol, 2025, 24(1): 344. doi:10.1186/s12933-025-02902-6 .
[30] QIU W, XIONG C, ZENG K, et al. The role of cardiovascular health in the associations between insulin resistance, future cardiovascular disease, and all-cause mortality[J]. Postgrad Med J, 2025, 101(1200): 1025-1033. doi:10.1093/postmj/qgaf033 .
[31] 秦合伟, 牛雨晴, 宋雪梅, 等. 血管软化丸抑制血管炎症反应防治动脉粥样硬化的分子机制[J]. 实用医学杂志, 2022, 38(15): 1901-1907. doi:10.3969/j.issn.1006-5725.2022.15.010 .
[32] LIU Z, DENG B, HUANG Q, et al. Comparison of seven surrogate insulin resistance indexes for predicting the prevalence of carotid atherosclerosis in normal-weight individuals[J]. Front Public Health, 2023, 11: 1241523. doi:10.3389/fpubh. 2023. 1241523 .
[33] ADAMS-HUET B, ZUBIRáN R, REMALEY A T, et al. The triglyceride-glucose index is superior to homeostasis model assessment of insulin resistance in predicting metabolic syndrome in an adult population in the United States[J]. J Clin Lipidol, 2024, 18(4): e518-e524. doi:10.1016/j.jacl.2024.04.130 .
[34] COLANTONI A, BUCCI T, COCOMELLO N, et al. Lipid-based insulin-resistance markers predict cardiovascular events in metabolic dysfunction associated steatotic liver disease[J]. Cardiovasc Diabetol, 2024, 23(1): 175. doi:10.1186/s12933-024-02263-6 .
文章导航

/